UCB’s Kygevvi receives positive CHMP opinion for thymidine kinase 2 deficiency
TK2d is an extremely rare disease characterised by severe and progressive muscle weakness
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Study shows infants given RSV vaccination benefit beyond first RSV season
The RSV virus is highly contagious and can cause serious respiratory illness for infants
Lilly announces acquisition of Ventyx Biosciences for around $1.2bn
Multiple Ventyx drugs are currently in phase 2 development for inflammatory disease
UCB’s Kygevvi receives positive CHMP opinion for thymidine kinase 2 deficiency
TK2d is an extremely rare disease characterised by severe and progressive muscle weakness
Celebrating Excellence in Healthcare Partnerships Awards!
The Awards were sponsored by Inizio, Chase, druid and Robotics AI
Genentech increases investment to $2bn for US manufacturing site
Roche and Genentech have a current commitment of $50bn for US manufacturing
Latest content
THX Pharma appoints Julien Veys as Deputy CEO
Veys has served at THX for almost a decade, including as Chief Operating Officer
Read More
ViCentra appoints Reman McDonagh as Vice President, Global Marketing
McDonagh has held senior leadership positions at Roche, Medtronic, Cellnovo and Insulet
Read More
TECregen appoints Klaas P Zuideveld as CEO
Zuideveld was most recently CEO of Versameb, and has held senior roles at Caris Life Sciences and Roche
Read More
Indegene appoints Jill DeSimone to Board of Directors
DeSimone was formerly President of US Oncology at Merck
Read More
Intelligence
Medicine shortages strike again – can radio-frequency identification technology help?
RFID has emerged as a key technology for its rapid, accurate data capture, and track and trace capabilities for manufacturing and supply chain operations
Read More
Pandemic readiness is now a financial risk test – and the UK must treat it that way
COVID-19 showed how quickly a health emergency becomes a fiscal event: disrupting supply chains, reshaping capital allocation and exposing governance weaknesses
Read More
Designing healthcare AI that works for every patient
As generative AI becomes more embedded in clinical decision-making, ensuring safety, accuracy and relevance is critical
Read More
Oral health and systemic disease: why they may be more closely linked than we thought
P. gingivalis, a type of bacteria found in the mouth, is linked to autoimmune diseases like rheumatoid arthritis
Read More
ASH 2025: where Magic Kingdom met the spirit of Andor
At ASH 2025, bold science and immersive experience bumped shoulders with a clear call to fight for patients
Read More
Alzheimer’s disease – the future of diagnosis and treatment in Europe
Recognising symptoms early and acting quickly can make a real difference to the lives of patients
Read More
Blogs
Latest
HRW’s Environmental Efforts Recognised with ‘B’ for Transparency by CDP
February 17, 2026 | Healthcare Research Worldwide|Sustainability, market research
HRW has been recognised by CDP, the global environmental disclosure organisation, for its commitment to sustainability and environmental transparency. In its first submission to CDP’s …
EpilepsyMeds receives Highly Commended recognition at Excellence in Healthcare Partnership Awards 2026
February 17, 2026 | Genetic Digital|Digital pharma, EHP Awards, Epilepsy, apps
EpilepsyMeds received Highly Commended recognition at the Excellence in Healthcare Partnership Awards 2026, celebrating the collaboration between Desitin Pharma, ChangeMed and Genetic Digital in advancing …
Uniphar | Clinical merges with BMclinical to strengthen global clinical trial services
February 16, 2026 | Uniphar|
Leading global healthcare services provider Uniphar announces a strategic merger between Uniphar | Clinical and BMclinical, reinforcing Uniphar | Clinical’s integrated clinical supply offering and solidifying its position as a trusted partner to pharmaceutical and biotech companies worldwide. …
The Greatest Form of Caring: Medscape’s Commitment to Advancing Cardiovascular Health
February 13, 2026 | Medscape Education|ACC26, Cardiology Education, HeartMonth
A February Focus on the Heart While February is known as the month of love, it is also National Heart Month, a time for highlighting …
AI, Agility, and Connected Impact at Alliance 2026
February 12, 2026 | Medscape Education|AI, Alliance26, ConnectedCare, patient outcomes
Join the Medscape team in Atlanta, February 16–19, 2026, as Alliance celebrates 50 years of excellence in continuing education for health professionals. We’re bringing our …
Winning in Pharma: the power of early strategic planning with patients
February 17, 2026 | Amiculum|Early strategic planning, Launch strategy, Patient partnership, Pharma Strategy, patient engagement
By Zoë van Helmond
Turn payer insights into impact with omnichannel engagement in market access
February 17, 2026 | Amiculum|Market Access, omnichannel
By Betty Charleshouse
What HCPs want from digital pharma in 2026: The value gap
February 16, 2026 | Graphite Digital|HCP Digital Engagement, HCP experience, Healthcare Digital Experience, Life Sciences Innovation, Pharma Digital Strategy
We’re proud to share Graphite’s 2026 research report. An in-depth look at how healthcare professionals experience digital engagement with life sciences today, and where the …
How can pharma build genuine partnerships with patient communities?
January 19, 2026 | Amiculum|patient advocacy, patient engagement
Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates must shape every stage of healthcare and medicines …
Five Predictions That Will Reshape Biopharma Commercialisation in 2026
January 5, 2026 | Nmblr|
Every year, we’re met with restructuring, hiring freezes, and portfolio cuts. And every year we tell ourselves the same story. It’s a rough patch. A …